https://business-news.org/article/472801-food-additives-permitted-in-feed-and-drinking-water-of-animals-ethyl-cellulose2026-10-17T01:44:04.222Z0.6https://business-news.org/article/472802-oncologic-drugs-advisory-committee-notice-of-meeting-establishment-of-a-public-docket-requ2026-10-17T01:44:04.235Z0.6https://business-news.org/article/472803-advisory-committee-obstetrics-reproductive-and-urologic-drugs-advisory-renewal2026-10-17T01:44:04.198Z0.6https://business-news.org/article/472804-advisory-committee-arthritis-advisory-committee-renewal2026-10-17T01:44:03.898Z0.6https://business-news.org/article/472805-agency-information-collection-activities-submission-for-office-of-management-and-budget-re2026-10-17T01:44:09.383Z0.6https://business-news.org/article/472806-agency-information-collection-activities-submission-for-office-of-management-and-budget-re2026-10-17T01:44:06.956Z0.6https://business-news.org/article/472807-marina-sievert-final-debarment-order2026-10-17T01:44:07.158Z0.6https://business-news.org/article/472808-standardized-format-for-electronic-submission-for-marketing-applications-content-for-the-p2026-10-17T01:44:06.775Z0.6https://business-news.org/article/472809-agency-information-collection-activities-proposed-collection-comment-request-medical-devic2026-10-17T01:44:07.230Z0.6https://business-news.org/article/472810-processes-and-practices-applicable-to-bioresearch-monitoring-inspections-draft-guidance-fo2026-10-17T01:44:09.363Z0.6https://business-news.org/article/472811-michael-terry-little-final-debarment-order2026-10-17T01:44:14.767Z0.6https://business-news.org/article/472812-pfizer-inc-et-al-withdrawal-of-approval-of-23-new-drug-applications2026-10-17T01:44:14.998Z0.6https://business-news.org/article/472813-shanif-abdul-punjani-final-debarment-order2026-10-17T01:44:06.891Z0.6https://business-news.org/article/472814-laboratory-accreditation-for-analyses-of-foods-program-implementation-determination-of-suf2026-10-17T01:44:06.989Z0.6https://business-news.org/article/472815-statement-of-organization-functions-and-delegations-of-authority2026-10-17T01:44:06.813Z0.6https://business-news.org/article/472816-hazard-analysis-and-risk-based-preventive-controls-for-human-food-draft-guidance-for-indus2026-10-17T01:44:07.462Z0.6https://business-news.org/article/472817-administrative-destruction2026-10-17T01:44:06.877Z0.6https://business-news.org/article/472818-advisory-committee-science-advisory-board-to-the-national-center-for-toxicological-researc2026-10-17T01:44:07.524Z0.6https://business-news.org/article/472819-agency-information-collection-activities-proposed-collection-comment-request-de-novo-class2026-10-17T01:44:00.894Z0.6https://business-news.org/article/472820-maria-anzures-camarena-final-debarment-order2026-10-17T01:44:00.826Z0.6https://business-news.org/article/472821-bayer-healthcare-pharmaceuticals-inc-et-al-withdrawal-of-approval-of-three-new-drug-applic2026-10-17T01:44:00.898Z0.6https://business-news.org/article/472822-platform-technology-designation-program-draft-guidance-for-industry-availability-agency-in2026-10-17T01:44:00.795Z0.6https://business-news.org/article/472823-issuance-of-priority-review-voucher-material-threat-medical-countermeasure-product-paxlovi2026-10-17T01:44:14.852Z0.6https://business-news.org/article/472824-authorization-of-emergency-use-of-a-drug-product-during-the-covid-19-pandemic-availability2026-10-17T01:44:15.120Z0.6https://business-news.org/article/472825-color-additive-certification-increase-in-fees-for-certification-services-extension-of-the-2026-10-17T01:44:06.900Z0.6https://business-news.org/article/472826-progynon-associates-et-al-proposal-to-withdraw-approval-of-four-new-drug-applications-oppo2026-10-17T01:44:01.263Z0.6https://business-news.org/article/472827-jessica-palacio-denial-of-hearing-final-debarment-order2026-10-17T01:44:01.380Z0.6https://business-news.org/article/472828-international-cooperation-on-harmonisation-of-technical-requirements-for-registration-of-v2026-10-17T01:44:07.105Z0.6https://business-news.org/article/472829-agency-information-collection-activities-proposed-collection-comment-request-class-ii-spec2026-10-17T01:43:47.093Z0.6https://business-news.org/article/472830-agency-information-collection-activities-proposed-collection-comment-request-yale-mayo-cli2026-10-17T01:43:46.773Z0.6https://business-news.org/article/472831-labeling-requirements-for-approved-or-conditionally-approved-new-animal-drugs-extension-of2026-10-17T01:43:46.647Z0.6https://business-news.org/article/472832-evaluating-immunosuppressive-effects-of-in-utero-exposure-to-drug-and-biologic-products-pu2026-10-17T01:43:46.925Z0.6https://business-news.org/article/472833-vaccines-and-related-biological-products-advisory-committee-amendment-of-notice-selection-2026-10-17T01:43:46.915Z0.6https://business-news.org/article/472834-program-policy-and-procedures-manual-guide-1240-3605-regulating-animal-foods-with-drug-cla2026-10-17T01:43:47.186Z0.6https://business-news.org/article/472835-ophthalmic-devices-reclassification-of-ultrasound-cyclodestructive-device2026-10-17T01:43:47.500Z0.6https://business-news.org/article/472836-revocation-of-two-authorizations-of-emergency-use-of-in-vitro-diagnostic-device-for-detect2026-10-17T01:43:47.613Z0.6https://business-news.org/article/472837-lonza-greenwood-llc-filing-of-color-additive-petition2026-10-17T01:43:47.433Z0.6https://business-news.org/article/472838-issuance-of-priority-review-voucher-rare-pediatric-disease-product-xolremdi-mavorixafor2026-10-17T01:43:50.632Z0.6https://business-news.org/article/472839-helsinn-healthcare-sa-withdrawal-of-approval-of-new-drug-application-for-truseltiq-infigra2026-10-17T01:43:50.846Z0.6https://business-news.org/article/472840-agency-information-collection-activities-proposed-collection-comment-request-food-and-cosm2026-10-17T01:43:50.985Z0.6https://business-news.org/article/472841-index-of-legally-marketed-unapproved-new-animal-drugs-for-minor-species2026-10-17T01:43:50.546Z0.6https://business-news.org/article/472842-new-animal-drugs-approval-of-new-animal-drug-applications-withdrawal-of-approval-of-new-an2026-10-17T01:43:50.859Z0.6https://business-news.org/article/472843-gina-acosta-final-debarment-order2026-10-17T01:43:50.671Z0.6https://business-news.org/article/472844-issuance-of-priority-review-voucher-rare-pediatric-disease-product-ojemda-tovorafenib2026-10-17T01:43:50.974Z0.6https://business-news.org/article/472845-determination-of-regulatory-review-period-for-purposes-of-patent-extension-jemperli2026-10-17T01:43:51.288Z0.6https://business-news.org/article/472846-remanufacturing-of-medical-devices-guidance-for-industry-entities-that-perform-servicing-o2026-10-17T01:43:52.881Z0.6https://business-news.org/article/472847-modified-risk-tobacco-product-application-renewal-application-for-iqos-3-0-system-holder-a2026-10-17T01:43:52.756Z0.6https://business-news.org/article/472848-modified-risk-tobacco-product-application-renewal-applications-for-iqos-2-4-system-holder-2026-10-17T01:43:52.967Z0.6https://business-news.org/article/472849-psychopharmacologic-drugs-advisory-committee-notice-of-meeting-establishment-of-a-public-d2026-10-17T01:43:34.798Z0.6https://business-news.org/article/472850-peripheral-and-central-nervous-system-drugs-advisory-committee-notice-of-meeting-establish2026-10-17T01:43:34.730Z0.6https://business-news.org/article/472851-risk-evaluation-and-mitigation-strategy-logic-model-a-framework-to-link-program-design-wit2026-10-17T01:43:35.349Z0.6https://business-news.org/article/472852-adam-paul-runsdorf-final-debarment-order2026-10-17T01:43:35.189Z0.6https://business-news.org/article/472853-fresenius-kabi-usa-llc-et-al-withdrawal-of-approval-of-12-abbreviated-new-drug-application2026-10-17T01:43:35.358Z0.6https://business-news.org/article/472854-statement-of-organization-functions-and-delegations-of-authority2026-10-17T01:43:34.794Z0.6https://business-news.org/article/472855-statement-of-organization-functions-and-delegations-of-authority2026-10-17T01:43:34.975Z0.6https://business-news.org/article/472856-the-tobacco-products-scientific-advisory-committee-notice-of-meeting2026-10-17T01:43:52.831Z0.6https://business-news.org/article/472857-international-cooperation-on-harmonisation-of-technical-requirements-for-registration-of-v2026-10-17T01:43:35.839Z0.6https://business-news.org/article/472858-standards-for-the-growing-harvesting-packing-and-holding-of-produce-for-human-consumption-2026-10-17T01:43:35.745Z0.6https://business-news.org/article/472859-medical-devices-laboratory-developed-tests2026-10-17T01:43:35.722Z0.6https://business-news.org/article/472860-enforcement-policy-for-certain-in-vitro-diagnostic-devices-for-immediate-public-health-res2026-10-17T01:43:35.800Z0.6https://business-news.org/article/472861-consideration-of-enforcement-policies-for-tests-during-a-section-564-declared-emergency-dr2026-10-17T01:43:35.383Z0.6https://business-news.org/article/472862-request-for-nominations-of-a-nonvoting-representative-of-the-interest-of-tobacco-growers-o2026-10-17T01:44:06.960Z0.6https://business-news.org/article/472863-angela-maria-giron-final-debarment-order2026-10-17T01:43:53.414Z0.6https://business-news.org/article/472864-agency-information-collection-activities-proposed-collection-comment-request-new-animal-dr2026-10-17T01:43:53.248Z0.6https://business-news.org/article/472865-heritable-intentional-genomic-alterations-in-animals-the-approval-process-draft-guidance-f2026-10-17T01:43:48.731Z0.6https://business-news.org/article/472866-heritable-intentional-genomic-alterations-in-animals-risk-based-approach-guidance-for-indu2026-10-17T01:43:48.631Z0.6https://business-news.org/article/472867-safety-testing-of-human-allogeneic-cells-expanded-for-use-in-cell-based-medical-products-d2026-10-17T01:43:49.055Z0.6https://business-news.org/article/472868-considerations-for-the-use-of-human-and-animal-derived-materials-and-components-in-the-man2026-10-17T01:43:48.727Z0.6https://business-news.org/article/472869-listening-session-optimizing-the-food-and-drug-administration-s-use-of-and-processes-for-a2026-10-17T01:43:48.589Z0.6https://business-news.org/article/472870-endocrinologic-and-metabolic-drugs-advisory-committee-notice-of-meeting-establishment-of-a2026-10-17T01:44:06.890Z0.6https://business-news.org/article/472871-content-and-format-of-composition-statement-and-corresponding-statement-of-ingredients-in-2026-10-17T01:43:51.092Z0.6https://business-news.org/article/472872-raw-data-for-safety-and-effectiveness-studies-draft-guidance-for-industry-availability2026-10-17T01:43:48.996Z0.6https://business-news.org/article/472873-veterinary-feed-directive-regulation-questions-and-answers-small-entity-compliance-guide-g2026-10-17T01:43:45.144Z0.6https://business-news.org/article/472874-food-additives-permitted-in-feed-and-drinking-water-of-animals-condensed-extracted-glutami2026-10-17T01:43:44.727Z0.6https://business-news.org/article/472875-determination-that-fludarabine-phosphate-injection-50-milligrams-2-milliliter-was-not-with2026-10-17T01:43:44.624Z0.6https://business-news.org/article/472876-revocation-of-uses-of-partially-hydrogenated-oils-in-foods-guidance-for-industry-small-ent2026-10-17T01:43:44.524Z0.6https://business-news.org/article/472877-cancer-clinical-trial-eligibility-criteria-laboratory-values-draft-guidance-for-industry-i2026-10-17T01:43:51.020Z0.6https://business-news.org/article/472878-cancer-clinical-trial-eligibility-criteria-washout-periods-and-concomitant-medications-dra2026-10-17T01:43:50.922Z0.6https://business-news.org/article/472879-cancer-clinical-trial-eligibility-criteria-performance-status-draft-guidance-for-industry-2026-10-17T01:43:50.803Z0.6https://business-news.org/article/472880-agency-information-collection-activities-proposed-collection-comment-request-pregnancy-exp2026-10-17T01:43:47.722Z0.6https://business-news.org/article/472881-filing-of-food-additive-petition-from-environmental-defense-fund-breast-cancer-prevention-2026-10-17T01:43:39.014Z0.6https://business-news.org/article/472882-agency-information-collection-activities-submission-for-office-of-management-and-budget-re2026-10-17T01:43:42.367Z0.6https://business-news.org/article/472883-agency-information-collection-activities-proposed-collection-comment-request-electronic-us2026-10-17T01:43:37.361Z0.6https://business-news.org/article/472884-promoting-effective-drug-development-identifying-opportunities-and-priorities-for-the-food2026-10-17T01:43:31.316Z0.6https://business-news.org/article/472885-agency-information-collection-activities-announcement-of-office-of-management-and-budget-a2026-10-17T01:43:31.142Z0.6https://business-news.org/article/472886-recommendations-for-collecting-representative-samples-for-food-testing-used-as-evidence-fo2026-10-17T01:43:30.983Z0.6https://business-news.org/article/472887-color-additive-certification-increase-in-fees-for-certification-services-reopening-of-the-2026-10-17T01:43:31.168Z0.6https://business-news.org/article/472888-promotional-labeling-and-advertising-considerations-for-prescription-biological-reference-2026-10-17T01:43:31.836Z0.6https://business-news.org/article/472889-pai-holdings-llc-dba-pharmaceutical-associates-inc-et-al-withdrawal-of-approval-of-23-new-2026-10-17T01:43:30.358Z0.6https://business-news.org/article/472890-molecular-and-clinical-genetics-panel-of-the-medical-devices-advisory-committee-notice-of-2026-10-17T01:43:30.168Z0.6https://business-news.org/article/472891-report-on-the-performance-of-drug-and-biologics-firms-in-conducting-postmarketing-requirem2026-10-17T01:43:29.947Z0.6https://business-news.org/article/472892-issuance-of-priority-review-voucher-rare-pediatric-disease-product-lenmeldy-atidarsagene-a2026-10-17T01:43:25.702Z0.6https://business-news.org/article/472893-final-decision-on-withdrawal-of-pepaxto-melphalan-flufenamide-following-appeal-of-the-prop2026-10-17T01:43:25.673Z0.6https://business-news.org/article/472894-center-for-drug-evaluation-and-research-center-for-clinical-trial-innovation2026-10-17T01:43:25.560Z0.6https://business-news.org/article/472895-determination-that-kemstro-baclofen-orally-disintegrating-tablets-10-milligrams-and-20-mil2026-10-17T01:43:38.889Z0.6https://business-news.org/article/472896-determination-that-vistaril-hydroxyzine-pamoate-oral-suspension-25-milligrams-5-milliliter2026-10-17T01:43:26.127Z0.6https://business-news.org/article/472897-agency-information-collection-activities-submission-for-office-of-management-and-budget-re2026-10-17T01:43:26.117Z0.6https://business-news.org/article/472898-issuance-of-priority-review-voucher-rare-pediatric-disease-product-duvyzat-givinostat2026-10-17T01:43:25.539Z0.6https://business-news.org/article/472899-21st-century-cures-act-annual-compilation-of-notices-of-updates-from-the-susceptibility-te2026-10-17T01:43:21.845Z0.6https://business-news.org/article/472900-determination-that-nalfon-fenoprofen-calcium-oral-capsules-equivalent-to-300-milligram-bas2026-10-17T01:43:26.748Z0.6https://business-news.org/article/472901-financial-transparency-and-efficiency-of-the-prescription-drug-user-fee-act-biosimilar-use2026-10-17T01:43:26.503Z0.6https://business-news.org/article/472902-pediatric-oncology-subcommittee-of-the-oncologic-drugs-advisory-committee-notice-of-meetin2026-10-17T01:43:26.407Z0.6https://business-news.org/article/472903-robert-lance-shuffert-final-debarment-order2026-10-17T01:43:26.469Z0.6https://business-news.org/article/472904-determination-that-glucotrol-glipizide-tablets-5-milligrams-and-10-milligrams-were-not-wit2026-10-17T01:43:24.276Z0.6https://business-news.org/article/472905-request-for-nominations-for-voting-members-for-the-patient-engagement-advisory-committee2026-10-17T01:43:24.053Z0.6https://business-news.org/article/472906-new-dietary-ingredient-notification-master-files-for-dietary-supplements-draft-guidance-fo2026-10-17T01:43:13.681Z0.6https://business-news.org/article/472907-data-integrity-for-in-vivo-bioavailability-and-bioequivalence-studies-draft-guidance-for-i2026-10-17T01:43:13.247Z0.6https://business-news.org/article/472908-product-specific-guidance-for-oxymetazoline-hydrochloride-draft-guidance-for-industry-avai2026-10-17T01:43:13.387Z0.6https://business-news.org/article/472909-electronic-submission-of-expedited-safety-reports-from-investigational-new-drug-exempt-bio2026-10-17T01:43:08.960Z0.6https://business-news.org/article/472910-providing-regulatory-submissions-in-electronic-format-investigational-new-drug-application2026-10-17T01:43:08.891Z0.6https://business-news.org/article/472911-animal-studies-for-dental-bone-grafting-material-devices-premarket-notification-510-k-subm2026-10-17T01:43:16.479Z0.6https://business-news.org/article/472912-specgx-llc-et-al-withdrawal-of-approval-of-30-abbreviated-new-drug-applications2026-10-17T01:43:09.977Z0.6https://business-news.org/article/472913-over-the-counter-monograph-drug-user-fee-program-facility-fee-rates-for-fiscal-year-20242026-10-17T01:43:09.866Z0.6https://business-news.org/article/472914-handling-and-retention-of-bioavailability-and-bioequivalence-testing-samples-guidance-for-2026-10-17T01:43:16.562Z0.6https://business-news.org/article/472915-agency-information-collection-activities-submission-for-office-of-management-and-budget-re2026-10-17T01:43:16.702Z0.6https://business-news.org/article/472916-agency-information-collection-activities-announcement-of-office-of-management-and-budget-a2026-10-17T01:43:24.393Z0.6https://business-news.org/article/472917-agency-information-collection-activities-proposed-collection-comment-request-national-agri2026-10-17T01:43:16.475Z0.6https://business-news.org/article/472918-oncologic-drugs-advisory-committee-notice-of-meeting-establishment-of-a-public-docket-requ2026-10-17T01:43:16.594Z0.6https://business-news.org/article/472919-determination-that-isuprel-isoproterenol-hydrochloride-injection-0-2-milligrams-per-millil2026-10-17T01:43:13.405Z0.6https://business-news.org/article/472920-clovis-oncology-inc-astrazeneca-pharmaceuticals-lp-and-glaxosmithkline-llc-withdrawal-of-a2026-10-17T01:43:18.537Z0.6https://business-news.org/article/472921-astrazeneca-pharmaceuticals-lp-withdrawal-of-approval-of-new-drug-application-for-lynparza2026-10-17T01:43:18.508Z0.6https://business-news.org/article/472922-electronic-submissions-data-standards-support-and-requirement-for-the-clinical-data-interc2026-10-17T01:43:18.481Z0.6https://business-news.org/article/472923-phillip-leonowens-final-debarment-order2026-10-17T01:43:18.081Z0.6https://business-news.org/article/472924-banned-devices-proposal-to-ban-electrical-stimulation-devices-for-self-injurious-or-aggres2026-10-17T01:43:16.757Z0.6https://business-news.org/article/472925-martin-valdes-final-debarment-order2026-10-17T01:43:09.780Z0.6https://business-news.org/article/472926-hazard-analysis-and-risk-based-preventive-controls-for-human-food-draft-guidance-for-indus2026-10-17T01:43:09.755Z0.6https://business-news.org/article/472927-food-additives-food-contact-substance-notification-that-is-no-longer-effective2026-10-17T01:43:08.752Z0.6https://business-news.org/article/472928-agency-information-collection-activities-proposed-collection-comment-request-regulations-u2026-10-17T01:43:08.998Z0.6https://business-news.org/article/472929-agency-information-collection-activities-proposed-collection-comment-request-veterinary-fe2026-10-17T01:43:09.534Z0.6https://business-news.org/article/472930-eli-lilly-and-company-withdrawal-of-approval-of-sarafem-fluoxetine-hydrochloride-capsules-2026-10-17T01:42:53.205Z0.6https://business-news.org/article/472931-willis-reed-final-debarment-order2026-10-17T01:42:52.938Z0.6https://business-news.org/article/472932-revocation-of-six-authorizations-of-emergency-use-of-in-vitro-diagnostic-device-for-detect2026-10-17T01:42:52.932Z0.6https://business-news.org/article/472933-agency-information-collection-activities-proposed-collection-comment-request-voluntary-tot2026-10-17T01:42:52.769Z0.6https://business-news.org/article/472934-real-world-evidence-considerations-regarding-non-interventional-studies-for-drug-and-biolo2026-10-17T01:42:52.825Z0.6https://business-news.org/article/472935-drug-products-or-categories-of-drug-products-that-present-demonstrable-difficulties-for-co2026-10-17T01:42:53.300Z0.6https://business-news.org/article/472936-air-products-and-chemicals-inc-withdrawal-of-approval-of-a-new-drug-application-and-new-an2026-10-17T01:42:53.440Z0.6https://business-news.org/article/472937-early-alzheimer-s-disease-developing-drugs-for-treatment-draft-guidance-for-industry-avail2026-10-17T01:42:53.739Z0.6https://business-news.org/article/472938-controlled-correspondence-related-to-generic-drug-development-guidance-for-industry-availa2026-10-17T01:42:53.662Z0.6https://business-news.org/article/472939-manufacture-of-batches-in-support-of-original-new-animal-drug-applications-abbreviated-new2026-10-17T01:42:53.949Z0.6https://business-news.org/article/472940-pharmacokinetics-in-patients-with-impaired-renal-function-study-design-data-analysis-and-i2026-10-17T01:42:53.797Z0.6https://business-news.org/article/472941-bayer-healthcare-pharmaceuticals-inc-withdrawal-of-approval-of-new-drug-application-for-al2026-10-17T01:42:53.396Z0.6https://business-news.org/article/472942-evaluation-of-thermal-effects-of-medical-devices-that-produce-tissue-heating-and-or-coolin2026-10-17T01:43:24.307Z0.6https://business-news.org/article/472943-determination-that-nucynta-tapentadol-hydrochloride-solution-equivalent-20-milligrams-base2026-10-17T01:43:16.145Z0.6https://business-news.org/article/472944-requests-for-feedback-and-meetings-for-medical-device-submissions-the-q-submission-program2026-10-17T01:43:13.471Z0.6https://business-news.org/article/472945-determination-that-duexis-ibuprofen-and-famotidine-tablet-800-milligrams-and-26-6-milligra2026-10-17T01:43:08.780Z0.6https://business-news.org/article/472946-medical-devices-technical-amendments2026-10-17T01:43:09.130Z0.6https://business-news.org/article/472947-frozen-cherry-pie-revocation-of-a-standard-of-identity-and-a-standard-of-quality2026-10-17T01:43:09.980Z0.6https://business-news.org/article/472948-hoffmann-la-roche-inc-et-al-withdrawal-of-approval-of-two-new-drug-applications-correction2026-10-17T01:43:13.530Z0.6https://business-news.org/article/472949-determination-of-regulatory-review-period-for-purposes-of-patent-extension-cibinqo2026-10-17T01:43:13.695Z0.6https://business-news.org/article/472950-determination-of-regulatory-review-period-for-purposes-of-patent-extension-vtama2026-10-17T01:43:16.650Z0.6https://business-news.org/article/472951-determination-of-regulatory-review-period-for-purposes-of-patent-extension-pyrukynd2026-10-17T01:43:16.437Z0.6https://business-news.org/article/472952-e2d-r1-post-approval-safety-data-definitions-and-standards-for-management-and-reporting-of2026-10-17T01:43:09.580Z0.6https://business-news.org/article/472953-determination-of-regulatory-review-period-for-purposes-of-patent-extension-daurismo2026-10-17T01:43:08.863Z0.6https://business-news.org/article/472954-determination-that-romidepsin-injection-10-milligrams-2-milliliters-5-milligrams-millilite2026-10-17T01:42:53.081Z0.6https://business-news.org/article/472955-select-updates-for-the-premarket-cybersecurity-guidance-section-524b-of-the-federal-food-d2026-10-17T01:42:53.055Z0.6https://business-news.org/article/472956-agency-information-collection-activities-proposed-collection-comment-request-proposed-smal2026-10-17T01:42:53.145Z0.6https://business-news.org/article/472957-annual-reportable-labeling-changes-for-new-drug-applications-and-abbreviated-new-drug-appl2026-10-17T01:42:53.112Z0.6https://business-news.org/article/472958-agency-information-collection-activities-submission-for-office-of-management-and-budget-re2026-10-17T01:43:09.409Z0.6https://business-news.org/article/472959-agency-information-collection-activities-proposed-collection-comment-request-new-plant-var2026-10-17T01:43:09.034Z0.6https://business-news.org/article/472960-advisory-committee-pharmaceutical-science-and-clinical-pharmacology-advisory-committee-ren2026-10-17T01:43:16.170Z0.6https://business-news.org/article/472961-filing-of-color-additive-petition-from-phytolon-ltd2026-10-17T01:42:53.487Z0.6https://business-news.org/article/472962-agency-information-collection-activities-proposed-collection-comment-request-establishment2026-10-17T01:42:52.794Z0.6https://business-news.org/article/472963-determination-of-regulatory-review-period-for-purposes-of-patent-extension-light-adjustabl2026-10-17T01:42:47.144Z0.6https://business-news.org/article/472964-early-alzheimer-s-disease-developing-drugs-for-treatment-draft-guidance-for-industry-avail2026-10-17T01:42:46.955Z0.6https://business-news.org/article/472965-labeling-requirements-for-approved-or-conditionally-approved-new-animal-drugs2026-10-17T01:42:47.003Z0.6https://business-news.org/article/472966-revocation-of-emergency-use-of-a-drug-product-during-the-covid-19-pandemic-availability2026-10-17T01:42:47.106Z0.6https://business-news.org/article/472967-assessing-covid-19-related-symptoms-in-outpatient-adult-and-adolescent-subjects-in-clinica2026-10-17T01:42:37.311Z0.6https://business-news.org/article/472968-blood-products-advisory-committee-notice-of-meeting-establishment-of-a-public-docket-reque2026-10-17T01:42:37.361Z0.6https://business-news.org/article/472969-advisory-committee-gastrointestinal-drugs-advisory-committee-renewal2026-10-17T01:42:37.257Z0.6https://business-news.org/article/472970-q2-r2-validation-of-analytical-procedures-and-q14-analytical-procedure-development-interna2026-10-17T01:42:37.115Z0.6https://business-news.org/article/472971-advisory-committee-genetic-metabolic-diseases-advisory-committee-addition-to-list-of-stand2026-10-17T01:42:37.891Z0.6https://business-news.org/article/472972-notice-of-the-denial-of-a-hearing-request-regarding-a-proposal-to-refuse-to-approve-a-supp2026-10-17T01:42:37.712Z0.6https://business-news.org/article/472973-agency-information-collection-activities-proposed-collection-comment-request-survey-on-the2026-10-17T01:42:37.713Z0.6https://business-news.org/article/472974-dietary-supplements-new-dietary-ingredient-notification-procedures-and-timeframes-guidance2026-10-17T01:42:37.628Z0.6https://business-news.org/article/472975-agency-information-collection-activities-submission-for-office-of-management-and-budget-re2026-10-17T01:42:38.083Z0.6https://business-news.org/article/472976-vaccines-and-related-biological-products-advisory-committee-notice-of-meeting-establishmen2026-10-17T01:42:52.650Z0.6https://business-news.org/article/472977-determination-of-regulatory-review-period-for-purposes-of-patent-extension-sotyktu2026-10-17T01:42:47.725Z0.6https://business-news.org/article/472978-determination-of-regulatory-review-period-for-purposes-of-patent-extension-fyarro2026-10-17T01:42:47.637Z0.6https://business-news.org/article/472979-determination-of-regulatory-review-period-for-purposes-of-patent-extension-relyvrio2026-10-17T01:42:38.199Z0.6https://business-news.org/article/472980-determination-of-regulatory-review-period-for-purposes-of-patent-extension-voxzogo2026-10-17T01:42:38.324Z0.6https://business-news.org/article/472981-determination-of-regulatory-review-period-for-purposes-of-patent-extension-sapien-3-ultra-2026-10-17T01:42:38.273Z0.6https://business-news.org/article/472982-key-information-and-facilitating-understanding-in-informed-consent-draft-guidance-for-spon2026-10-17T01:42:53.017Z0.6https://business-news.org/article/472983-food-and-drug-administration-modernization-act-of-1997-modifications-to-the-list-of-recogn2026-10-17T01:42:40.626Z0.6https://business-news.org/article/472984-clinical-pharmacology-considerations-for-antibody-drug-conjugates-guidance-for-industry-av2026-10-17T01:42:41.147Z0.6https://business-news.org/article/472985-determination-of-regulatory-review-period-for-purposes-of-patent-extension-inqovi2026-10-17T01:42:52.733Z0.6https://business-news.org/article/472986-determination-of-regulatory-review-period-for-purposes-of-patent-extension-ongentys2026-10-17T01:42:45.334Z0.6https://business-news.org/article/472987-determination-of-regulatory-review-period-for-purposes-of-patent-extension-klisyri2026-10-17T01:42:45.298Z0.6https://business-news.org/article/472988-determination-of-regulatory-review-period-for-purposes-of-patent-extension-isturisa2026-10-17T01:42:45.172Z0.6https://business-news.org/article/472989-determination-of-regulatory-review-period-for-purposes-of-patent-extension-leqvio2026-10-17T01:42:45.197Z0.6https://business-news.org/article/472990-determination-of-regulatory-review-period-for-purposes-of-patent-extension-prevnar-202026-10-17T01:42:43.029Z0.6https://business-news.org/article/472991-determination-of-regulatory-review-period-for-purposes-of-patent-extension-xerava2026-10-17T01:42:42.545Z0.6https://business-news.org/article/472992-determination-of-regulatory-review-period-for-purposes-of-patent-extension-nulibry2026-10-17T01:42:42.555Z0.6https://business-news.org/article/472993-determination-of-regulatory-review-period-for-purposes-of-patent-extension-veklury2026-10-17T01:42:42.631Z0.6https://business-news.org/article/472994-determination-of-regulatory-review-period-for-purposes-of-patent-extension-gemtesa2026-10-17T01:42:42.492Z0.6https://business-news.org/article/472995-determination-of-regulatory-review-period-for-purposes-of-patent-extension-opdualag2026-10-17T01:42:40.340Z0.6https://business-news.org/article/472996-determination-of-regulatory-review-period-for-purposes-of-patent-extension-camcevi2026-10-17T01:42:41.088Z0.6https://business-news.org/article/472997-determination-of-regulatory-review-period-for-purposes-of-patent-extension-evrysdi2026-10-17T01:42:40.767Z0.6https://business-news.org/article/472998-determination-of-regulatory-review-period-for-purposes-of-patent-extension-aduhelm2026-10-17T01:42:40.761Z0.6https://business-news.org/article/472999-determination-of-regulatory-review-period-for-purposes-of-patent-extension-sogroya2026-10-17T01:42:40.956Z0.6https://business-news.org/article/473000-determination-of-regulatory-review-period-for-purposes-of-patent-extension-evkeeza2026-10-17T01:42:40.645Z0.6